Comparison effect ofmefenamic acid and tranexamic acid in the treatment of bleeding secondary to the use of IUD
Phase 2
- Conditions
- menorrhagia.
- Registration Number
- IRCT201205092515N8
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 84
Inclusion Criteria
willingness to cooperate in women
using TCU380 (IUD); no experiment coagulation disorders and systemic disorders; none ultrasound malignancies; counting padding to verify menorrhagia; none use of other methods of contraception;
no disease of the digestive and liver, brain and kidney; no trombosis; no history of allergy to mefenamic acid and hemoglobin; no history thrombosis and clotting disorders; no history of irregular uterine bleeding; uterine size between 9-6 cm; hemoglobin above 10; having 1 to 5 parity and no unwanted pregnancy.
Exclusion criteria: sensitivity to the drug use
the drug note continued; dissatisfaction with the plan; unwanted pregnancy with IUD and IUD removal.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Menorrhagia. Timepoint: before intervention and first and second months after intervention. Method of measurement: PBAC Table.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: One month and two months after intervention. Method of measurement: Standard questionnaire.